Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction: Results of a randomized, placebo-controlled, dose- ranging trial

E. Magnus Ohman, Neal S. Kleiman, Gerald Gacioch, Seth J. Worley, Frank I. Navetta, J. David Talley, H. Vernon Anderson, Stephen G. Ellis, Mark D. Cohen, Douglas Spriggs, Michael Miller, Dean Kereiakes, Steven Yakubov, Michael M. Kitt, Kristina N. Sigmon, Robert M. Califf, Mitchell W. Krucoff, Eric J. Topol

Research output: Contribution to journalArticlepeer-review

397 Scopus citations

Fingerprint

Dive into the research topics of 'Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction: Results of a randomized, placebo-controlled, dose- ranging trial'. Together they form a unique fingerprint.

Medicine & Life Sciences